Can a drug FDA approved for endometriosis become a mainstay for nonsurgical treatment of HMB in women with fibroids?
Elagolix is a GnRH antagonist that is approved in a 2-dose schedule for treatment of endometriosis. It is given...
A decision tree model and outcomes analysis showed vaginal surgery as safe, effective, and feasible.
From the Journals
ACGME data show a significant decrease in the total number of hysterectomies performed by residents.
LAS VEGAS – Ovaries may be active in women as late as their 70s.
Physician experience is the most important determinant for which minimally invasive approach is used to perform hysterectomy.
In a minimally invasive approach to hysterectomy, one of the most difficult situations is the truly large uterus – greater than 2,500 grams.
LAS VEGAS – Hysterectomies are linked to various negative outcomes, expert says.
Product update: Neuromodulation device, cystoscopy simplified, hysteroscopy seal, next immunization frontier
NEW SACRAL NEUROMODULATION DEVICE
Axonics Modulation Technologies, Inc. announced the first implantation of its recently US Food...
News for Your Practice
Yes, according to data from phase 3 trials
Whether or not women experience symptoms from uterine fibroid(s) can be...
VANCOUVER – Women with preoperative depression were more likely to have a comorbid pain disorder, compared with...
What do results from the Women’s Health Initiative’s 18-year follow-up study reveal?